Literature DB >> 15282712

Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain.

Kyeung Min Joo1, Yoon Hee Chung, Min Kyu Kim, Ryoung Hee Nam, Byung Lan Lee, Kyung Hoon Lee, Choong Ik Cha.   

Abstract

To examine the distributions of VIP/PACAP receptors (VPAC1, VPAC2, and PAC1 receptors) in the brain and to identify the cell types that express these receptors, we performed immunohistochemistry and double immunofluorescence in the rat brain with specific antibodies. The immunohistochemistry revealed that the receptors had distinctive, complementary, and overlapping distribution patterns. High levels of the VPAC1 receptor were expressed in the cerebral cortex, hippocampal formation, deep cerebellar nuclei, thalamus, hypothalamus, and brainstem. The VPAC2 receptors were concentrated in the cerebral cortex, hippocampal formation, amygdalar regions, cerebellar cortex, deep cerebellar nuclei, hypothalamus, and brainstem. On the other hand, the PAC1 receptors had a more restricted distribution pattern in the brain, and high levels of the PAC1 receptors were confined to the cerebellar cortex, deep cerebellar nuclei, epithalamus, hypothalamus, brainstem, and white matter of many brain regions. Also, many fibers expressing the PAC1 receptors were observed in various areas, i.e., the thalamus, hypothalamus, and brainstem. The double immunofluorescence showed that the VIP/PACAP receptors were confined to the neuroglia as well as the neurons. All three types of the VIP/PACAP receptors were expressed in the astrocytes, and the PAC1 receptors were also expressed in the oligodendrocytes. These findings indicate that VIP and PACAP exert their functions through their receptors in specific locations in different combinations. We hope that this first demonstration of the distributions of the VIP/PACAP receptors provides data useful in the investigation of the mechanisms of the many functions of VIP and PACAP in the brain, which require further elucidation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282712     DOI: 10.1002/cne.20231

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  69 in total

1.  Spatiotemporal distribution of vasoactive intestinal polypeptide receptor 2 in mouse suprachiasmatic nucleus.

Authors:  Sungwon An; Connie Tsai; Julie Ronecker; Alison Bayly; Erik D Herzog
Journal:  J Comp Neurol       Date:  2012-08-15       Impact factor: 3.215

2.  Expression of pituitary adenylate cyclase-activating polypeptide 1 and 2 receptor mRNA in gallbladder tissue of patients with gallstone or gallbladder polyps.

Authors:  Zhen-Hai Zhang; Shuo-Dong Wu; Hong Gao; Gang Shi; Jun-Zhe Jin; Jing Kong; Zhong Tian; Yang Su
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

3.  Effects of VPAC1 activation in nucleus ambiguus neurons.

Authors:  Florin Liviu Gherghina; Andrei Adrian Tica; Elena Deliu; Mary E Abood; G Cristina Brailoiu; Eugen Brailoiu
Journal:  Brain Res       Date:  2016-12-30       Impact factor: 3.252

4.  Pituitary Adenylate Cyclase-Activating Peptide in the Central Amygdala Causes Anorexia and Body Weight Loss via the Melanocortin and the TrkB Systems.

Authors:  Attilio Iemolo; Antonio Ferragud; Pietro Cottone; Valentina Sabino
Journal:  Neuropsychopharmacology       Date:  2015-02-04       Impact factor: 7.853

5.  Augmented cystine-glutamate exchange by pituitary adenylate cyclase-activating polypeptide signaling via the VPAC1 receptor.

Authors:  Jon M Resch; Rebecca Albano; Xiaoqian Liu; Julie Hjelmhaug; Doug Lobner; David A Baker; Sujean Choi
Journal:  Synapse       Date:  2014-08-06       Impact factor: 2.562

6.  Vasoactive intestinal peptide acts via multiple signal pathways to regulate hippocampal NMDA receptors and synaptic transmission.

Authors:  Kai Yang; Catherine H Trepanier; Hongbin Li; Michael A Beazely; Ethan A Lerner; Michael F Jackson; John F MacDonald
Journal:  Hippocampus       Date:  2009-09       Impact factor: 3.899

7.  Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system.

Authors:  Nicholas J Justice; Zung Fan Yuan; Paul E Sawchenko; Wylie Vale
Journal:  J Comp Neurol       Date:  2008-12-01       Impact factor: 3.215

8.  PACAP increases Arc/Arg 3.1 expression within the extended amygdala after fear conditioning in rats.

Authors:  Edward G Meloni; Karen T Kaye; Archana Venkataraman; William A Carlezon
Journal:  Neurobiol Learn Mem       Date:  2018-11-17       Impact factor: 2.877

9.  The Role of VIP in Social Behavior: Neural Hotspots for the Modulation of Affiliation, Aggression, and Parental Care.

Authors:  Marcy A Kingsbury; Leah C Wilson
Journal:  Integr Comp Biol       Date:  2016-12       Impact factor: 3.326

10.  Characterization of the thermoregulatory response to pituitary adenylate cyclase-activating polypeptide in rodents.

Authors:  Eszter Banki; Eszter Pakai; Balazs Gaszner; Csaba Zsiboras; Andras Czett; Paras Rahul Parkash Bhuddi; Hitoshi Hashimoto; Gabor Toth; Andrea Tamas; Dora Reglodi; Andras Garami
Journal:  J Mol Neurosci       Date:  2014-07-04       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.